Total Funding
30
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
139655
Marinus Pharmaceuticals reformulates, develops, and commercializes drugs to treat neurological, psychiatric, and pain disorders.
Michael S. Saporito: Vice President of Research and Preclinical DevelopmentPast Role: Melior Pharmaceuticals, Chief Science Officer, Co-Founder- Edward Smith: Vice President and Chief Financial Officer
About the Company
Marinus Pharmaceuticals focuses on creating therapies aimed at improving the lives of individuals affected by seizure disorders. The company emphasizes innovation through cutting-edge science and collaborates with healthcare professionals to enhance patient care.
